Update: On January 13, 2022, the U.S. Supreme Court issued a decision allowing the health care staff vaccination requirement to stand. Below are links to updated CMS resources that provide guidance on the vaccination requirement.
CMS FAQ: External FAQ IFC-6 – 1.21.22 (cms.gov)
State timelines: CMS Omnibus COVID-19 Health Care Staff Vaccination Rule – Implementation Timeline
Vaccine requirement decision tree: Do the CMS staff vaccination requirements apply to my facility?
Litigation update: Current emergencies | CMS
Background
In late December 2021, the Centers for Medicare and Medicaid Services (CMS) released guidance on the Health Care Staff Vaccination Interim Final Rule. The emergency regulation requires vaccinations for eligible staff at health care facilities participating in the Medicare and Medicaid programs.
Where It Applies
The staff vaccination requirement applies to the following Medicare and Medicaid-certified provider and supplier types:
- Ambulatory Surgery Centers
- Community Mental Health Centers
- Comprehensive Outpatient Rehabilitation Facilities
- Critical Access Hospitals
- End-Stage Renal Disease Facilities
- Home Health Agencies
- Home Infusion Therapy Suppliers
- Hospices
- Hospitals
- Intermediate Care Facilities for Individuals with Intellectual Disabilities
- Clinics
- Rehabilitation Agencies
- Public Health Agencies as Providers of Outpatient Physical Therapy and Speech-Language Pathology Services
- Psychiatric Residential Treatment Facilities (PRTFs) Programs for All-Inclusive Care for the Elderly Organizations (PACE)
- Rural Health Clinics/Medicare Federally Qualified Health Centers
- Long Term Care facilities
Implementation and Enforcement By State
Per CMS, implementation and enforcement of this regulation does NOT apply to the following States at this time: Alabama, Alaska, Arizona, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, New Hampshire, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Texas, Utah, West Virginia, and Wyoming. Facilities in these states are not required to comply with the rule, pending future developments in litigation.
The rule applies to facilities participating in the Medicare and Medicaid programs in the remaining 25 states, the District of Columbia, and the territories.
What Must Be Done
Facilities covered by this regulation must establish a policy ensuring all eligible staff have received the first dose of a two-dose COVID-19 vaccine or a one-dose COVID-19 vaccine prior to providing any care, treatment, or other services by January 27, 2022, 30 days following the publication of the guidance. All eligible staff must have received the necessary shots to be fully vaccinated – either two doses of Pfizer or Moderna or one dose of Johnson & Johnson – by February 28, 2022, 60 days following the publication of the guidance.
IMPORTANT
This is an area of evolving regulation and enforcement. The Academy will publish updated information as it is available.
Additional CMS Resources
Related Posts
American Telemedicine Association Publishes New Health Data Privacy Principles
Amid rising concerns about data privacy within the telehealth arena, the American Telemedicine Association (ATA) released a set of principles to ensure patient data is protected during telehealth utilization. The ATA’s Health Data Privacy Principles include six components: The ATA states that a federal policy would offer much-needed consistency in data privacy practices for telehealth providers…
New Federal Resource on Protecting the Privacy and Security of Consumer’s Health Information
The Federal Trade Commission (FTC) and the Department of Health and Human Services (HHS) recently released a joint publication that provides guidance and practical advice to all entities that collect, share, or use consumer information. Collecting, Using, or Sharing Consumer Health Information gathers all of the various legal obligations in one place and focuses on…
Congressional White Paper Recommends a Sector-by-Sector Approach to Regulating Artificial Intelligence
Senate Health Committee ranking Republican Bill Cassidy (LA) released a white paper on September 6 suggesting Congress refrain from crafting a government-wide approach to overseeing artificial intelligence and only step in when an agency’s oversight falls short, such as filling gaps in U.S. Food and Drug Administration’s (FDA) ability to regulate artificial intelligence (AI) as…